US FDA approves first biosimilar to Roche's cancer drug Rituxan

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The U.S. Food and Drug Administration on Wednesday approved Celltrion Inc's Truxima, making it the first biosimilar to Roche Holding AG's Rituxan ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Roche buys US biotech Jecure in race for liver disease drugsSwiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche drops Alzheimer drug trials after setbackRoche Holding will halt two late-stage clinical trials of its crenezumab drug in early Alzheimer's disease after an interim analysis indicated it ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche seeks to freshen up Kadcyla label amid biosimilar defenseRoche aims to broaden use of its Kadcyla breast cancer drug as the Swiss pharmaceuticals giant defends itself against rivals who are moving in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Novartis goes after Roche asthma medicine Xolair with new drugNovartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »